Sangamo Therapeutics, Inc. · NASDAQ:SGMO

Macrae Sandy had 12,613 Sangamo Therapeutics, Inc. shares withheld for tax (Form 4)

Traded May 25, 2026 · Filed May 27, 2026

On May 25, 2026, Macrae Sandy (Director, PRESIDENT, CEO AND DIRECTOR) had 12,613 Sangamo Therapeutics, Inc. shares withheld for tax at US$0.17 for US$2,144, leaving 1,895,043 shares. Filed May 27, 2026 (Form 4).

Withheld for tax
12,613 shares
Price
US$0.17
Value
US$2,144
Holding after
1,895,043 shares
Trading plan
No
Role
Director, PRESIDENT, CEO AND DIRECTOR

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 25, 2026Common StockShares withheld for tax12,613US$0.171,895,043Direct

Source

View original at SEC

Related